Biocruces Bizkaia Health Research Institute, 48903 Barakaldo, Spain.
Spanish Consortium for Research on Rare Diseases (CIBERER), 28029 Madrid, Spain.
Genes (Basel). 2020 Jan 2;11(1):51. doi: 10.3390/genes11010051.
X-linked intellectual disability (XLID) is known to contribute up to 10% of intellectual disability (ID) in males and could explain the increased ratio of affected males observed in patients with ID. Over the past decade, next-generation sequencing has clearly stimulated the gene discovery process and has become part of the diagnostic procedure. We have performed targeted next-generation sequencing of 82 XLID genes on 61 non-related male patients with suggestive non-syndromic XLID. These patients were initially referred to the molecular genetics laboratory to exclude Fragile X Syndrome. The cohort includes 47 male patients with suggestive X-linked family history of ID meaning that they had half-brothers or maternal cousins or uncles affected; and 14 male patients with ID and affected brothers whose mothers show skewed X-inactivation. Sequencing data analysis identified 17 candidate variants in 16 patients. Seven families could be re-contacted and variant segregation analysis of the respective eight candidate variants was performed: , , , , , , and . Our results show the utility of targeted next-generation sequencing in unravelling the genetic origin of XLID, especially in retrospective cases. Variant segregation and additional studies like RNA sequencing and biochemical assays also helped in re-evaluating and further classifying the genetic variants found.
X 连锁智力障碍(XLID)已知占男性智力障碍(ID)的 10%,并可能解释了 ID 患者中受影响男性比例增加的原因。在过去的十年中,下一代测序技术明显刺激了基因发现过程,并成为诊断程序的一部分。我们对 61 名无关联的男性 XLID 患者进行了 82 个 XLID 基因的靶向下一代测序。这些患者最初被转介到分子遗传学实验室,以排除脆性 X 综合征。该队列包括 47 名具有提示性 X 连锁 ID 家族史的男性患者,即他们有同父异母兄弟或表亲或叔叔受影响;和 14 名 ID 男性患者和受影响的兄弟,其母亲表现出偏性 X 失活。测序数据分析在 16 名患者中鉴定出 17 个候选变体。可以重新联系到七个家庭,并对各自的八个候选变体进行变体分离分析:、、、、、、和。我们的结果表明,靶向下一代测序在揭示 XLID 的遗传起源方面非常有用,尤其是在回顾性病例中。变体分离和其他研究,如 RNA 测序和生化分析,也有助于重新评估和进一步分类发现的遗传变体。
Eur J Hum Genet. 2015-11
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2024-5-10
Genes (Basel). 2021-11-28
Mol Genet Genomic Med. 2019-4
Front Mol Neurosci. 2025-5-21
Neurol Genet. 2024-6-13
Int J Mol Epidemiol Genet. 2023-10-15
Front Cell Dev Biol. 2022-12-8
Clin Genet. 2019-11-24
Int J Mol Sci. 2019-6-21
Front Mol Neurosci. 2019-2-20
Am J Med Genet A. 2018-6